NYSE: GNW · Diversified Insurance
Genworth Financial (GNW) fair value and price range
As of 3 Oct 2026, Faircurve's model values Genworth Financial (GNW) at $9.06 a share. The stock last closed at $9.55, which puts the model's fair value 5.1% below the price. The model grades the evidence behind this valuation as low, so no verdict is shown. For banks, insurers and mortgage real estate investment trusts (REITs) the grade looks at how many comparable companies there are and how closely they agree, how wide the range of outcomes is, and whether the model's valuation methods agree with each other. It does not say how likely the fair value is to be right.
Revalued . Price is the close of 2 Oct 2026. Genworth Financial, Inc.
Faircurve Insights · 3 Oct 2026
Genworth Financial, Inc. provides mortgage and long-term care insurance products in the United States, operating through its Enact and Closed Block segments.
On 3 Oct 2026, Faircurve's model found a fair value of $9.06 a share for Genworth Financial, Inc., the midpoint of 2,000 simulations. This fair value was the same as the previous run on 26 Sep 2026. The calibrated range over 63 trading days was $7.56 to $10.98, built from the fair value, since there is no live options data for the stock, and calibrated weekly against realised prices, and ranges built this way held the price 60% of the time at this horizon. The model grades the evidence behind this valuation as low, so no verdict is shown.
Faircurve's model compares Genworth Financial, Inc. with The Hartford Insurance Group, Inc. and American International Group, Inc. The stock's moves around its last 8 earnings reports ranged from -7.5% to +16.9%, with a median size, ignoring direction, of 3.0%.
Written from the figures on this page for the 3 Oct 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give GNW?
The calibrated range for GNW over 63 trading days is $7.56 to $10.98. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,809 past valuations, refreshed 3 Oct 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $7.69 to $10.54. In 40% of the simulations the fair value came out above the price the model ran on.
How does GNW compare with similar companies?
The companies in diversified insurance closest to Genworth Financial in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| ACGL Arch Capital Group Ltd. | $93.60 | $114.68 | +22.5% | Low evidence grade |
| HIG The Hartford Insurance Group, Inc. | $126.05 | $158.51 | +25.8% | Undervalued |
| AIG American International Group, Inc. | $74.93 | $87.19 | +16.4% | Undervalued |
| BRK-B Berkshire Hathaway Inc. | $502.65 | $417.65 | -16.9% | Low evidence grade |
All diversified insurance stocks ranked by gap to fair value
When does GNW report earnings, and how has the stock reacted?
Genworth Financial's next earnings report is scheduled for 9 Nov 2026. Companies can move their dates.
How GNW moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 3.0%.
| Report date | Two session move |
|---|---|
| 5 Aug 2026 | -1.0% |
| 5 May 2026 | +3.4% |
| 23 Feb 2026 | -2.6% |
| 5 Nov 2025 | +0.7% |
| 30 Jul 2025 | -1.7% |
| 30 Apr 2025 | +16.9% |
| 18 Feb 2025 | -7.5% |
| 6 Nov 2024 | +7.0% |
Genworth Financial at a glance
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block.
- Market value
- $3.7B
- Sector
- Financial Services
- Industry
- Diversified Insurance
- Consensus revenue growth, next fiscal year
- -4.2%
- Analysts with estimates
- 1
- Beta to the US market
- 0.23
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices Genworth Financial on the share price against the net assets on the balance sheet, adjusted for the earnings analysts expect (price to book value), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 26 Sep 2026 the model's fair value for GNW was $9.06. It is unchanged at $9.06 as of 3 Oct 2026. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Genworth Financial's valuation
Is Genworth Financial stock undervalued or overvalued?
Faircurve's model puts GNW's fair value at $9.06 a share against a last close of $9.55, as of 3 Oct 2026. The model grades the evidence behind this valuation as low, so no verdict is shown. For banks, insurers and mortgage real estate investment trusts (REITs) the grade looks at how many comparable companies there are and how closely they agree, how wide the range of outcomes is, and whether the model's valuation methods agree with each other. It does not say how likely the fair value is to be right.
What is GNW's fair value?
$9.06 a share as of 3 Oct 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $7.69 to $10.54.
What price range does the model give GNW?
$7.56 to $10.98 over 63 trading days. Ranges built this way held the price 60% of the time across 4,809 past valuations, refreshed 3 Oct 2026.
When does Genworth Financial report earnings next?
The next report is scheduled for 9 Nov 2026. Companies can move their dates.
How much has GNW moved on past earnings reports?
Across its last 8 reports the median two session move was 3.0%, ignoring direction. The largest was +16.9% around the report of 30 Apr 2025.
How confident is the model in this valuation?
The model's evidence grade for GNW is low. For banks, insurers and mortgage real estate investment trusts (REITs) the grade looks at how many comparable companies there are and how closely they agree, how wide the range of outcomes is, and whether the model's valuation methods agree with each other. It is not a probability that the fair value is right, or that the price reaches it.